Answers are grounded in this paper and cite their sources.
For schizophrenia patients on stable antipsychotic treatment, adjunctive antidepressants are effective for total and particularly negative symptom reduction. However, effects are small-to-medium, differ across antidepressants, and negative symptom improvement seems restricted to the augmentation of FGAs.
No takes yet. Share an insight, caveat, or question.
Galling et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: